Bayer Nordic
Presence
Bayer Nordic is owned by Bayer.
Bayer is one of the...
Bayer is a company listed under the stock ticker BAYN (DE).
Bayer has a direct presence in 20 countries.Bayer has 42 subsidiaries including Ascensia Diabetes Care, AskBio and Askbio Europe.
They are in:
- Pharmaceuticals60%
- Biotechnology12%
- Other28%
Acquisition, funding and merger involving Bayer.
- Bayer has acquired AskBio (posted on October 27 2020).
- Bayer has announced the acquisition of Vividion Therapeutics (posted on August 9 2021).
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Bayer Nordic
- Tomer Feffer, Head, Pharmacuticals
- Anna Svahn, Head of Human Resources
- Jan Jakobsen, Managing Director and Head of Product Supply
Popular executive movements at Bayer
- Werner Baumann, Chief Executive Officer, will leave the company on Apr. 1, 2023 (posted on September 14 2022).
Create an alert
to follow the executive moves at Bayer Nordic.
Pharmaceuticals
Bayer has 1,989 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- Kate Farms has just announced a $75 Million fundraising. (posted on September 22 2022).
- AmerisourceBergen has announced the acquisition of PharmaLex (posted on September 16 2022).
- PharmEasy has just announced a $300 Million fundraising. (posted on September 13 2022).
Popular contacts in Pharmaceuticals
News
Press releases by Bayer Nordic
- Newsletter subscription
- Articles tagged with 'SPECIALIZED PRESS' | Bayer
- Articles tagged with 'Export-TopNews' | Bayer
- Articles tagged with 'Export-LatestNews' | Bayer
- Articles tagged with 'Export-TopNews' & 'Export-LatestNews' | Bayer
- Kerendia™ (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study
- Kimberly Mathisen appointed to the Supervisory Board of Bayer AG
- Bayer is advancing in the fight against cancer showcasing new study data at ESMO Congress 2022
- New data indicate positive effects of Kerendia™ (finerenone) on mortality in patients with chronic kidney disease and type 2 diabetes
- Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian
- View more press releases Close
Social media about Bayer Nordic
- Bayer Nordic on Wikipedia, Google News & Yahoo Finance
- Bayer Nordic on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Christiane Temminghoff 
Call Bayer Nordic at +46 85...
